Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BRTX
일자시간출처헤드라인심볼기업
2024/05/0105:15GlobeNewswire Inc.BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:BRTXBioRestorative Therapies Inc
2024/04/3020:30GlobeNewswire Inc.BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics TechnologyNASDAQ:BRTXBioRestorative Therapies Inc
2024/04/1623:25AllPennyStocks.comBiotech Catches Major Premarket Bid Following FDA ClearanceNASDAQ:BRTXBioRestorative Therapies Inc
2024/04/1620:45GlobeNewswire Inc.BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentNASDAQ:BRTXBioRestorative Therapies Inc
2024/04/0820:45GlobeNewswire Inc.BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
2024/04/0405:38GlobeNewswire Inc.BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsNASDAQ:BRTXBioRestorative Therapies Inc
2024/04/0120:45GlobeNewswire Inc.BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KNASDAQ:BRTXBioRestorative Therapies Inc
2024/03/1205:15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
2024/03/0706:34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:43Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1606:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1503:44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
2024/02/1223:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0922:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0906:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0622:05GlobeNewswire Inc.BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0522:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0521:30GlobeNewswire Inc.BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0206:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
2024/02/0121:30GlobeNewswire Inc.BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual MeetingNASDAQ:BRTXBioRestorative Therapies Inc
2023/12/1223:15GlobeNewswire Inc.BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramNASDAQ:BRTXBioRestorative Therapies Inc
2023/12/0606:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
2023/12/0207:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
 검색 관련기사 보기:NASDAQ:BRTX